| . | Congenital . | Cyclic . | Autoimmune/Idiopathic . | ||||
|---|---|---|---|---|---|---|---|
| Age, yr . | <18 . | ≥18 . | <18 . | ≥18 . | <18 . | ≥18 . | |
| Before G-CSF ANC | Median | 0.2 | 0.2 | 0.4 | 0.5 | 0.2 | 0.4 |
| Mean | 0.6 | 0.5 | 0.9 | 1.0 | 0.6 | 0.8 | |
| SEM | (±0.05) | (±0.05) | (±0.07) | (±0.07) | (±0.04) | (±0.04) | |
| Range | (0-22.5) | (0-33.4) | (0-30.1) | (0-36.5) | (0-34.6) | (0-38.5) | |
| Before G-CSF ALC | Median | 4.9 | 2.9 | 4.7 | 2.2 | 4.1 | 1.5 |
| Mean | 5.3 | 3.8 | 4.9 | 2.7 | 4.2 | 1.8 | |
| SEM | (±0.13) | (±0.15) | (±0.1 9) | (±0.13) | (±0.10) | (±0.05) | |
| Range | (0.04-20.6) | (0.01-18.7) | (0.4-14.6) | (0.03-28.2) | (0.18-16.0) | (0.04-54.6) | |
| G-CSF dosing (mcg/kg per day) | Median | 4.8 | 3.5 | 2.1 | 1.6 | 1.5 | 0.8 |
| Mean | 10.8 | 8.9 | 3.7 | 2.3 | 2.3 | 1.9 | |
| SEM | (±1.04) | (±1.12) | (±0.69) | (±0.15) | (±0.13) | (±0.15) | |
| Range | (0.03-536.9) | (0.01-283.5) | (0.1-48.9) | (0.01-33.7) | (0.01-40.0) | (0.01-42.9) | |
| After G-CSF ANC | Median | 1.3 | 1.5 | 1.9 | 2.5 | 2.2 | 2.1 |
| Mean | 2.6 | 3.3 | 4.0 | 5.2 | 3.9 | 3.7 | |
| SEM | (±0.12) | (±0.14) | (±0.36) | (±0.29) | (±0.16) | (±0.13) | |
| Range | (0-76.7) | (0-107.5) | (0-63.3) | (0-91.7) | (0-120.1) | (0-199.0) | |
| After G-CSF ALC | Median | 3.7 | 2.3 | 3.8 | 2.1 | 3.5 | 1.7 |
| Mean | 4.7 | 2.7 | 4.3 | 2.3 | 3.9 | 1.9 | |
| SEM | (±0.12) | (±0.09) | (±0.22) | (±0.05) | (±0.10) | (±0.05) | |
| Range | (0.0-76.2) | (0.0-49.8) | (0.01-45.7) | (0.0-44.5) | (0.0-39.3) | (0.0-74.0) | |
| G-CSF treatment, yr | Median | 4.3 | 17.9 | 4.5 | 17.1 | 2.0 | 9.2 |
| Mean | 5.3 | 16.9 | 5.4 | 16.3 | 3.2 | 10.7 | |
| SEM | (±0.22) | (±0.52) | (±0.48) | (±0.70) | (±0.17) | (±0.37) | |
| Range | (0-17.6) | (0-31.4) | (0-16.6) | (0-32.2) | (0-15.9) | (0-30.8) | |
| . | Congenital . | Cyclic . | Autoimmune/Idiopathic . | ||||
|---|---|---|---|---|---|---|---|
| Age, yr . | <18 . | ≥18 . | <18 . | ≥18 . | <18 . | ≥18 . | |
| Before G-CSF ANC | Median | 0.2 | 0.2 | 0.4 | 0.5 | 0.2 | 0.4 |
| Mean | 0.6 | 0.5 | 0.9 | 1.0 | 0.6 | 0.8 | |
| SEM | (±0.05) | (±0.05) | (±0.07) | (±0.07) | (±0.04) | (±0.04) | |
| Range | (0-22.5) | (0-33.4) | (0-30.1) | (0-36.5) | (0-34.6) | (0-38.5) | |
| Before G-CSF ALC | Median | 4.9 | 2.9 | 4.7 | 2.2 | 4.1 | 1.5 |
| Mean | 5.3 | 3.8 | 4.9 | 2.7 | 4.2 | 1.8 | |
| SEM | (±0.13) | (±0.15) | (±0.1 9) | (±0.13) | (±0.10) | (±0.05) | |
| Range | (0.04-20.6) | (0.01-18.7) | (0.4-14.6) | (0.03-28.2) | (0.18-16.0) | (0.04-54.6) | |
| G-CSF dosing (mcg/kg per day) | Median | 4.8 | 3.5 | 2.1 | 1.6 | 1.5 | 0.8 |
| Mean | 10.8 | 8.9 | 3.7 | 2.3 | 2.3 | 1.9 | |
| SEM | (±1.04) | (±1.12) | (±0.69) | (±0.15) | (±0.13) | (±0.15) | |
| Range | (0.03-536.9) | (0.01-283.5) | (0.1-48.9) | (0.01-33.7) | (0.01-40.0) | (0.01-42.9) | |
| After G-CSF ANC | Median | 1.3 | 1.5 | 1.9 | 2.5 | 2.2 | 2.1 |
| Mean | 2.6 | 3.3 | 4.0 | 5.2 | 3.9 | 3.7 | |
| SEM | (±0.12) | (±0.14) | (±0.36) | (±0.29) | (±0.16) | (±0.13) | |
| Range | (0-76.7) | (0-107.5) | (0-63.3) | (0-91.7) | (0-120.1) | (0-199.0) | |
| After G-CSF ALC | Median | 3.7 | 2.3 | 3.8 | 2.1 | 3.5 | 1.7 |
| Mean | 4.7 | 2.7 | 4.3 | 2.3 | 3.9 | 1.9 | |
| SEM | (±0.12) | (±0.09) | (±0.22) | (±0.05) | (±0.10) | (±0.05) | |
| Range | (0.0-76.2) | (0.0-49.8) | (0.01-45.7) | (0.0-44.5) | (0.0-39.3) | (0.0-74.0) | |
| G-CSF treatment, yr | Median | 4.3 | 17.9 | 4.5 | 17.1 | 2.0 | 9.2 |
| Mean | 5.3 | 16.9 | 5.4 | 16.3 | 3.2 | 10.7 | |
| SEM | (±0.22) | (±0.52) | (±0.48) | (±0.70) | (±0.17) | (±0.37) | |
| Range | (0-17.6) | (0-31.4) | (0-16.6) | (0-32.2) | (0-15.9) | (0-30.8) | |